Longeveron Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LGVN, updated each market day.
LGVN AI Sentiment
AI predicts Longeveron Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Longeveron Inc. Common Stock
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Sector
Exchange
Market Cap
$32,502,063
Cap Tier
Employees
38
Headquarters
MIAMI, FL
Listed Since
Feb. 12, 2021
Website
LGVN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LGVN Volatility
Longeveron Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
